• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥美拉唑对巴雷特食管胃食管反流的影响。

Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus.

作者信息

Fiorucci S, Santucci L, Farroni F, Pelli M A, Morelli A

机构信息

Department of Internal Medicine, Perugia University, Italy.

出版信息

Am J Gastroenterol. 1989 Oct;84(10):1263-7.

PMID:2801676
Abstract

Pattern of gastric and esophageal acidity were evaluated in 14 patients with endoscopically and histologically proven Barrett's esophagus, in 46 with slight-to-moderate esophagitis, and in 22 healthy subjects. In patients with Barrett's esophagus, LES pressure was considerably lower and percentage exposure to acid was considerably higher than in either patients with esophagitis or controls (p less than 0.001). Percentage of time with esophageal pH below 4 was 33.2% in patients with Barrett's esophagus, 14% in patients with slight-to-moderate esophagitis (p less than 0.001), and 3.4% in controls (p less than 0.001). In patients with Barrett's esophagus, the esophageal exposure to acid was similar in upright and supine positions, and the number of refluxes that lasted longer than 5 min was also greater in these patients than in uncomplicated esophagitis or controls (p less than 0.001). Accordingly, their acid-clearing capacity was markedly reduced (p less than 0.001 vs. control). Omeprazole 20 mg, given once daily, reduced both percentage of time with pH below 4 (p less than 0.001) and the number of episodes longer than 5 min (p less than 0.001), but had no effect on acid clearance. In patients with Barrett's esophagus, omeprazole lowered intragastric acidity by 77.8% (p less than 0.001). Median intragastric pH was 1.9 (1.7-2.1) pretreatment, and 4.5 (4.2-5) during omeprazole (p less than 0.001).

摘要

对14例经内镜和组织学证实患有巴雷特食管的患者、46例患有轻至中度食管炎的患者以及22名健康受试者的胃和食管酸度模式进行了评估。与食管炎患者或对照组相比,巴雷特食管患者的LES压力明显更低,酸暴露百分比明显更高(p<0.001)。巴雷特食管患者食管pH值低于4的时间百分比为33.2%,轻至中度食管炎患者为14%(p<0.001),对照组为3.4%(p<0.001)。在巴雷特食管患者中,食管在直立位和仰卧位时的酸暴露情况相似,且这些患者中持续时间超过5分钟的反流次数也比单纯性食管炎患者或对照组更多(p<0.001)。因此,他们的酸清除能力明显降低(与对照组相比,p<0.001)。每日服用一次20毫克奥美拉唑可降低pH值低于4的时间百分比(p<0.001)以及持续时间超过5分钟的发作次数(p<0.001),但对酸清除无影响。在巴雷特食管患者中,奥美拉唑可使胃内酸度降低77.8%(p<0.001)。奥美拉唑治疗前胃内pH值中位数为1.9(1.7 - 2.1),服用奥美拉唑期间为4.5(4.2 - 5)(p<0.001)。

相似文献

1
Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus.奥美拉唑对巴雷特食管胃食管反流的影响。
Am J Gastroenterol. 1989 Oct;84(10):1263-7.
2
Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present.如果存在巴雷特化生,反流性食管炎中的食管运动功能障碍和酸暴露会更严重。
Am J Gastroenterol. 1994 Mar;89(3):349-56.
3
Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.奥美拉唑和高剂量雷尼替丁对中重度食管炎患者胃酸度和胃食管反流的影响。
Am J Gastroenterol. 1990 Nov;85(11):1458-62.
4
Is Barrett's esophagus characterized by more pronounced acid reflux than severe esophagitis?巴雷特食管的特征是否为比严重食管炎更明显的胃酸反流?
Am J Gastroenterol. 1998 Jul;93(7):1068-72. doi: 10.1111/j.1572-0241.1998.00331.x.
5
Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.与反流性食管炎相比,Barrett食管中酸和胆汁反流增加以及质子泵抑制剂治疗的效果。
Am J Gastroenterol. 2001 Feb;96(2):331-7. doi: 10.1111/j.1572-0241.2001.03515.x.
6
Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.雷贝拉唑复合制剂和市售制剂对反流性食管炎患者食管和胃内pH值的控制:一项初步研究。 (注:原文中药物名称有误,正确的应该是雷贝拉唑,按照正确药物名翻译了,若按原文错误药物名翻译为:奥美拉唑复合制剂和市售制剂对反流性食管炎患者食管和胃内pH值的控制:一项初步研究。)
Can J Clin Pharmacol. 2009 Winter;16(1):e264-72. Epub 2009 Apr 21.
7
Functional foregut abnormalities in Barrett's esophagus.巴雷特食管的功能性前肠异常
J Thorac Cardiovasc Surg. 1993 Jan;105(1):107-11.
8
The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.日本巴雷特食管患者中幽门螺杆菌感染率及胃酸分泌状况
Am J Gastroenterol. 2004 Jul;99(7):1213-21. doi: 10.1111/j.1572-0241.2004.30313.x.
9
Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus.短节段和长节段巴雷特食管患者的食管测压及动态24小时pH监测
Am J Gastroenterol. 1998 Jun;93(6):916-9. doi: 10.1111/j.1572-0241.1998.00276.x.
10
Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.巴雷特食管患者反流症状完全消除并不能保证食管内酸反流正常化。
Am J Gastroenterol. 1998 May;93(5):711-6. doi: 10.1111/j.1572-0241.1998.211_a.x.

引用本文的文献

1
Distal esophageal acid exposure and poor esophageal clearance correlate with probability of progression in Barrett's esophagus as determined by the tissue systems pathology test.远端食管酸暴露和食管清除功能差与巴雷特食管进展的可能性相关,这是通过组织系统病理学检查确定的。
Surg Endosc. 2025 Jul 7. doi: 10.1007/s00464-025-11930-y.
2
Esophageal Acid Clearance During Random Swallowing Is Faster in Patients with Barrett's Esophagus Than in Healthy Controls.在随机吞咽过程中,巴雷特食管患者的食管酸清除速度比健康对照者更快。
J Neurogastroenterol Motil. 2016 Oct 30;22(4):630-642. doi: 10.5056/jnm16019.
3
The dose of omeprazole required to achieve adequate intraesophageal acid suppression in patients with gastroesophageal junction specialized intestinal metaplasia and Barrett's esophagus.
胃食管结合部特殊型肠化生和 Barrett 食管患者实现食管内充分抑酸所需的奥美拉唑剂量。
Dig Dis Sci. 2013 Aug;58(8):2253-60. doi: 10.1007/s10620-013-2763-1. Epub 2013 Jul 4.
4
Chemoprevention of esophageal adenocarcinoma.食管腺癌的化学预防。
Therap Adv Gastroenterol. 2008 Jul;1(1):7-18. doi: 10.1177/1756283X08093568.
5
24 hour ambulatory oesophageal pH monitoring in uncomplicated Barrett's oesophagus.单纯性巴雷特食管的24小时动态食管pH监测
Gut. 1994 Oct;35(10):1352-5. doi: 10.1136/gut.35.10.1352.
6
Optimizing acid suppression for treatment of acid-related diseases.优化抑酸治疗酸相关性疾病
Dig Dis Sci. 1995 Feb;40(2 Suppl):24S-49S. doi: 10.1007/BF02214870.
7
Intragastric acidity and serum gastrin after sufotidine.服用舒法替丁后的胃内酸度和血清胃泌素
Gut. 1990 Sep;31(9):1087-8. doi: 10.1136/gut.31.9.1087.
8
Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus.巴雷特食管基础胃酸分泌量与治疗所需雷尼替丁每日剂量之间的相关性。
Dig Dis Sci. 1992 Apr;37(4):570-6. doi: 10.1007/BF01307581.